Pharma Firms Will ‘Walk Away’ From Gene Therapies Unless Payers Share Risk

 
• By Eliza Slawther
  
Pharmaceutical companies will turn their backs on gene therapies if national agencies do not share risks
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pink Sheet

More from Rare Diseases